PepGen Inc. (PEPG)
3.78
-0.15
(-3.82%)
USD |
NASDAQ |
Nov 20, 16:00
3.78
0.00 (0.00%)
After-Hours: 16:15
PepGen Shareholders Equity (Quarterly) : 103.07M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 103.07M |
| June 30, 2026 | 119.53M |
| March 31, 2026 | 133.98M |
| December 31, 2025 | 147.44M |
| September 30, 2025 | 163.14M |
| June 30, 2025 | 71.16M |
| March 31, 2025 | 91.80M |
| December 31, 2024 | 118.62M |
| September 30, 2024 | 137.46M |
| June 30, 2024 | 155.04M |
| March 31, 2024 | 179.00M |
| December 31, 2023 | 108.42M |
| Date | Value |
|---|---|
| September 30, 2023 | 125.86M |
| June 30, 2023 | 147.28M |
| March 31, 2023 | 164.84M |
| December 31, 2022 | 179.63M |
| September 30, 2022 | 192.94M |
| June 30, 2022 | 210.22M |
| March 31, 2022 | 115.59M |
| December 31, 2021 | 133.09M |
| September 30, 2021 | 139.57M |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | 9.774M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Korsana Biosciences, Inc. | 416.53M |
| IRulya Therapeutics, Inc. | 78.11M |
| Q32 Bio, Inc. | 287.67M |
| Bridgebio Oncology Therapeutics, Inc. | 293.39M |
| Oncolytics Biotech, Inc. | -7.503M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 127.78M |
| Total Liabilities (Quarterly) | 24.71M |
| Debt to Equity Ratio | 0.1514 |
| Current Ratio | 8.702 |
| Net Debt Paydown Yield | 0.27% |